All News | FDA

Advertising & Promotion

Apr 22, 2018
District Court Dismisses Case Over Faxed Invitation To Free Dinner Discussion for Physicians
Apr 19, 2018
Iowa AG Reaches Settlement with ‘Smart Pill’ Marketers
Apr 19, 2018
Kentucky Sues J&J and Subsidiaries Over Opioid Marketing
Apr 19, 2018
Allergan To Pay $3.5 Million To Settle Device Defect, Other Allegations Brought Under False Claims Act
Apr 18, 2018
Sen. Sanders Introduces Opioid Marketing Bill
Apr 16, 2018
N.J. Legislature Considers Bills Banning Drug Ads
Apr 16, 2018
Small Study Finds Oncologists Receiving Payments More Likely To Prescribe Payors Drug
Apr 5, 2018
Fast Talking, Complexity Cause Major Statement Concerns
Apr 3, 2018
DOJ Moves To Participate in Opioid Lawsuit Settlement Discussions
Apr 3, 2018
NAD Recommends ‘Cardio Miracle’ Supplement Discontinue Challenged Claims

Good Clinical Practice

Jul 28, 2018
Protocol Complexity Hindering Trials
Jul 28, 2018
FDA Finalizes Guidance Closing Orphan Loophole
Jul 27, 2018
Survey Finds Few Clinical Sites Recruit at 100 Percent
Jul 27, 2018
NIH Delays Registration and Reporting for Basic Science Studies Involving Human Subjects
Jul 27, 2018
National Strategy Developed for Alzheimer’s Study Recruitment
Jul 26, 2018
FDA Issues Draft Guidance on Diet in IEM Drug Trials
Jul 26, 2018
ACRES Issues Trial Site Quality Standards
Jul 26, 2018
FDA, OHRP Asked To Investigate Two Sedative Trials
Jul 25, 2018
Vivli Trial Data-Sharing Platform Goes Live
Jul 23, 2018
Patients Want to Know if Researchers Find Serious Concerns in Electronic Health Records

U.S. Food Labeling

FDA Regulation & Enforcement

Jun 10, 2021
Study Finds Even Meals May Influence Insulin Prescriptions
Jun 9, 2021
11th Circuit: Florida Clinic’s Stem Cell Procedure Is Subject to FDA Regulation as an HCT/P
Jun 9, 2021
Supplement Firm Asks Court To Dismiss Class Action
Jun 2, 2021
Medicrea Settlement Continues Emerging DOJ Trend of Including Open Payments Violation Allegations in Settlements
May 28, 2021
FDA, FTC Send Joint Warning Letters to Five Companies
May 27, 2021
FDA’s Unapproved Drugs Initiative Is Reinstated; Updated Guidance on Enforcement Priorities Promised
May 26, 2021
OPDP Encourages Grouped Electronic Submissions
May 26, 2021
AMS Releases Results of 2020 NOP Enforcement Activity
May 20, 2021
FTC Settles with CBD Marketer Over False Claims
May 20, 2021
FDA Inspection Roadmap Reports COVID’s Impact, Outlines Factors That Will Set Future Priorities

Medical Devices

Copyright © Thompson FDA, a division of CBIS. All rights reserved.